Polyethylene glycol (PEG-400) was found to be an inexpensive, non-toxic, and effective medium for the one-pot synthesis of 1,2-disubstituted benzimidazoles in excellent yields. Eco-friendliness, low cost, high yields, and recyclability of the PEG-400 are the important features of this protocol.
From the point of view of crystal growth and design, it is interesting to study the effect of different isomers on the resulting structure. Single crystals of the organic salt benzimidazolium 3-nitrophthalate (BZD + •mNPA − ) have been grown by slow evaporation from methanol solution. Single crystal X-ray diffraction demonstrated that the crystal structure belongs to the monoclinic system with space group P2 1 /c. The properties of the functional groups have been studied by FTIR spectroscopy, FT-Raman spectral analysis and 1 H and 13 C NMR spectroscopy. The emission spectra of BZD + •mNPA − were recorded in different solvents; they exhibit a negative solvatochromatic effect when the polarity of the solvent is increased. The thermal stability, dielectric constant and dielectric loss have been investigated and the HOMO and LUMO energy levels have been calculated using density functional theory (DFT). The crystal structure of BZD + •mNPA − has been compared with that of benzimidazolium 2-nitroterephthalate (BZD + •NTPh − ). The interactions of the isomers 3-nitrophthalate or 2-nitroterephthalate salts with benzimidazolium are very similar; however, the different positions of the carboxyl groups on the benzene rings changes the layout of the structure, which leads to undulating sheets for 3-nitrophthalate and flat antiparallel sheets for 2-nitrotherephthalate. The salt decomposes at around 180 °C.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.